N-Terminal Pro-Brain Natriuretic Peptide Levels Are Associated with Post-Stroke In-Hospital Complications

Previous studies have shown the relationship between N-terminal pro-brain natriuretic peptide (NT-proBNP) with stroke mortality and functional outcome after an acute ischemic stroke (AIS). Knowledge of its association with systemic and neurological in-hospital complications is scarce. Our objective...

Full description

Saved in:
Bibliographic Details
Published in:Journal of personalized medicine 2023-03, Vol.13 (3), p.474
Main Authors: Ruiz-Franco, María Luisa, Guevara-Sánchez, Eva, Amaya-Pascasio, Laura, Quesada-López, Miguel, Arjona-Padillo, Antonio, García-Torrecillas, Juan Manuel, Martínez-Sánchez, Patricia
Format: Article
Language:English
Subjects:
Analysis
Angina pectoris
Biomarkers
Blood pressure
Brain natriuretic peptide
Canada
Cardiac arrhythmia
Cardiovascular disease
Complications and side effects
Convulsions & seizures
Fever
Heart failure
Hypertension
Ischemia
Laboratories
Medical prognosis
Medical research
Medicine, Experimental
Mortality
Multivariate analysis
Natriuretic peptides
Neurological complications
Patients
Peptides
Precision medicine
Spain
Statistical analysis
Stroke
Stroke (Disease)
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Previous studies have shown the relationship between N-terminal pro-brain natriuretic peptide (NT-proBNP) with stroke mortality and functional outcome after an acute ischemic stroke (AIS). Knowledge of its association with systemic and neurological in-hospital complications is scarce. Our objective is to analyze this. We performed an observational, retrospective study that included consecutive AIS patients during a 1-year period (2020). A multivariate analysis was performed to identify if NT-proBNP levels were independently associated with in-hospital complications. 308 patients were included, of whom 96 (31.1%) developed systemic and 62 (20.12%) neurological in-hospital complications. Patients with any complication (39.3%) showed higher NT-proBNP levels than those without (median (IQR): 864 (2556) vs. 142 (623) pg/dL, < 0.001). The receiver operating characteristic curve (ROC) pointed to 326 pg/dL of NT-proBNP as the optimal cutoff level for developing in-hospital systemic complications (63.6% sensitivity and 64.7% specificity for any complication; 66.7% and 62.7% for systemic; and 62.9% and 57.7% for neurological complications). Multivariate analyses showed that NT-proBNP > 326 pg/dL was associated with systemic complications (OR 2.336, 95% CI: 1.259-4.335), adjusted for confounders. This did not reach statistical significance for neurological complications. NT-proBNP could be a predictor of in-hospital systemic complications in AIS patients. Further studies are needed.
ISSN:2075-4426
2075-4426
DOI:10.3390/jpm13030474